ReviewDrugs & aging2001
A practical guide to antimicrobial management of complicated urinary tract infection.
Review in Drugs & aging, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- The use of initial dosing of gentamicin in the management of pyelonephritis/urosepsis: A retrospective study.PloS one · 2019Trial
- Clinical characteristics and nomogram model for predicting the risk of recurrence of complicated urinary tract infection in pediatric patients.Scientific reports · 2024Article
- Current and Emerging Treatment Options for Multidrug ResistantAntibiotics (Basel, Switzerland) · 2022Review
- Septic discitis and septic pulmonary emboli: rare complications ofBMJ case reports · 2021Article
- Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal women.Life science alliance · 2021Article
- Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies.Archives of microbiology · 2020Review
- Prevalence and antibiotic susceptibility pattern of uropathogens in outpatients at a tertiary care hospital.New microbes and new infections · 2020Article
- Prevalence, risk factors and microorganisms of urinary tract infections in patients with type 2 diabetes mellitus: a retrospective study in China.Therapeutics and clinical risk management · 2018 · on this mapArticle
- Management of Asymptomatic Bacteriuria, Urinary Catheters and Symptomatic Urinary Tract Infections in Patients Undergoing Surgery for Joint Replacement: A Position Paper of the Expert Group 'Infection' ofJournal of bone and joint infection · 2017Review
- A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.Journal of nephrology · 2016Review
- Critical evaluation of ceftolozane-tazobactam for complicated urinary tract and intra-abdominal infections.Therapeutics and clinical risk management · 2016Review
- A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis.The Korean journal of internal medicine · 2015Article
- Antibiotic Susceptibility Pattern of ESβL Producing Klebsiella pneumoniae Isolated from Urine Samples of Pregnant Women in Karnataka.Journal of clinical and diagnostic research : JCDR · 2014Article
- Usability application of multiplex polymerase chain reaction in the diagnosis of microorganisms isolated from urine of patients treated in cancer hospital.Radiology and oncology · 2013Article
- Antimicrobial prescribing in nursing homes in Northern Ireland: results of two point-prevalence surveys.Drugs & aging · 2011Article
- Differences in the pattern of antibiotic prescription profile and recurrence rate for possible urinary tract infections in women with and without diabetes.Diabetes care · 2008Article
- Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.Clinical microbiology reviews · 2008Review
- Complicated urinary tract infection in adults.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2005Article
- Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.Drugs · 2004Review
- Management of bacterial urinary tract infections in adult patients with diabetes mellitus.Drugs · 2002Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complicated urinary tract infection occurs in the setting of a functionally or structurally abnormal genitourinary tract. Many different abnormalities may lead to a designation of complicated urinary tract infection, and these abnormalities will have different influences on the frequency of infection and likelihood of relapse or reinfection. The microbiology of complicated urinary tract infection is characterised by a greater variety of organisms and increased likelihood of antimicrobial resistance compared with acute uncomplicated urinary tract infection. Appropriate management requires a urine specimen for culture prior to institution of antimicrobial therapy, and ensuring that the underlying abnormality is fully characterised to determine whether it can be corrected. A wide variety of antimicrobial agents are effective for treatment, and are usually given for 7 to 14 days. If the underlying abnormality can be corrected, subsequent infections may be prevented. However, if the underlying abnormality cannot be corrected a high recurrence rate of infection, approaching 50% by 4 to 6 weeks, is expected. Further study of complicated urinary tract infection is necessary, including determination of when asymptomatic bacteriuria warrants treatment, and exploration of nonantimicrobial approaches to management.
Indexed as
Identifiers
11341472What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.